GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascentage Pharma Group International (FRA:36X) » Definitions » Asset Impairment Charge

Ascentage Pharma Group International (FRA:36X) Asset Impairment Charge : €0.0 Mil (TTM As of Jun. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Ascentage Pharma Group International Asset Impairment Charge?

Ascentage Pharma Group International's Asset Impairment Charge for the six months ended in Jun. 2024 was €0.0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 was €0.0 Mil.

Ascentage Pharma Group International Asset Impairment Charge Historical Data

The historical data trend for Ascentage Pharma Group International's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ascentage Pharma Group International Asset Impairment Charge Chart

Ascentage Pharma Group International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Asset Impairment Charge
Get a 7-Day Free Trial Premium Member Only - - - - -

Ascentage Pharma Group International Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Asset Impairment Charge Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Ascentage Pharma Group International Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.0 Mil.

Ascentage Pharma Group International Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Ascentage Pharma Group International's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Ascentage Pharma Group International Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ascentage Pharma Group International (FRA:36X) » Definitions » Asset Impairment Charge
Comparable Companies
HKSE:06826 HKSE:02410 HKSE:01952 HKSE:02162 HKSE:02696 HKSE:09969 HKSE:09995 HKSE:02171 HKSE:09966 HKSE:02157 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
AAPG:USA ASPHF:USA 06855:Hong Kong 36X:Germany
Address
68 Xinqing Road, Suzhou Industrial Park, Jiangsu, Suzhou, CHN, 215000
Website
https://www.ascentagepharma.com
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The company's geographical segments include the United States and Mainland China.

Ascentage Pharma Group International Headlines

No Headlines